Webinars & e-learning courses All webinars

Canine and feline lymphoma - diagnosis and treatment

Canine and feline lymphoma - diagnosis and treatment
Canine and feline lymphoma - diagnosis and treatment

Canine and feline lymphoma is a relatively common disease but there are some areas where potential complications arise. This webinar will concentrate on the diagnostic tests that can be utilised for this disease and the common treatments, with an emphasis on how the diagnostic tests can influence the treatment and prognosis. In dogs, diagnosis is usually relatively straightforward, but it can be more of a challenge in cats due to the differences in clinical presentation. The standard initial treatment options are well described, but how they need to be modified dependent on concurrent illnesses, diagnostic test findings and owner constraints can be more complicated. My approach to these issues will be described including how they might impact the patient outcome, as well as alternatives. The monitoring of the patients and an overview of the management of complications of the disease and treatment is to be covered. The webinar will conclude with rescue options. Lymphoma can be a rewarding disease to treat, but can be very challenging at times.

Recording from 22.03.2018

Speaker:

Peter_bennett_130x130.jpg

Peter Bennett

Dr Peter Bennett BVSc FANZCVS (Canine Medicine) DACVIM (Oncology, Small Animal Internal Medicine)

Dr Bennett is a graduate of the University of Melbourne. After time in general practice he completed residency training in small animal medicine in 1999 and then joined the faculty of Purdue University in Indiana where he was trained in oncology. He is a Fellow of the Australian and New Zealand College of Veterinary Scientists (Canine Medicine) and a Diplomate of the American College of Veterinary Internal Medicine (Oncology, Small Animal Internal Medicine). Peter is a member of a consensus statement committee for the American College on Veterinary Internal Medicine on the topic of Chemotherapy Safety.

Booking information

Duration: 0:59 h
Speaker: Peter Bennett
from 1
54.90 US$
(incl. tax)

You might also be interested in

lumbectomies 300x200.png
Barney Dean
1:07 h

Don't Get Stumped by Lumps - Approaching Tricky Lumpectomies 

This webinar will discuss the rationale behind sound investigation and management of tricky mass removals, and how to adapt a plan to suit owner circumstances. 
 
webinar-pic 3x2.jpg
Stephanie Colthurst
0:51 h

Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats

Tumors of the skin and subcutaneous tissues are the most common malignancies in dogs and cats accounting for over 30-40% of tumors in dogs and 29% in cats...
tumor-grading-and-prognosis-in-veterinary-practice-1.jpeg
Sara Belluco
0:44 h

Tumor grading and prognosis in veterinary practice

Tumors are quite frequent in companion animals, with malignant forms representing 56% of all the tumors in dogs and 80% in cats. Predicting the survival time and treatment response for malignant tumors is necessary to evaluate the best care options for the animal. Histological tumor grading helps veterinarians to define the prognosis, but each tumor has its own grading system with different prognosis, in terms of survival rate, metastatic rate, recurrence incidence. It could be not so easy to get your bearings in the pathologic words of gradings. The goal of this seminar is to be able to correlate the validated prognosis to each tumor grading we will see. We will rapidly review what tumor grading is and how it is evaluated. Then we will spend some time to review some of the most important tumor gradings (mammary tumors, mast cell tumors, melanomas, soft tissue sarcomas) and the correlated and validated prognostic factors. At the end of the seminar you will be able to clearly understand your pathologist’s report based on the grading system, and to use it to give an appropriate prognosis to the owners.